CMJAX
Price
$41.35
Change
-$0.28 (-0.67%)
Updated
Sep 20 closing price
VMCPX
Price
$352.79
Change
-$0.65 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

CMJAX vs VMCPX

Header iconCMJAX vs VMCPX Comparison
Open Charts CMJAX vs VMCPXBanner chart's image
Calvert US Mid Cap Core Rspnb Idx A
Price$41.35
Change-$0.28 (-0.67%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index InstitutionalPlus
Price$352.79
Change-$0.65 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CMJAX vs VMCPX Comparison Chart
Loading...
VS
CMJAX vs. VMCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMJAX is a Buy and VMCPX is a Buy.

FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 172B vs. CMJAX (471M). VMCPX pays higher dividends than CMJAX: VMCPX (1.51) vs CMJAX (0.77). CMJAX was incepted earlier than VMCPX: CMJAX (9 years) vs VMCPX (14 years). CMJAX is a more actively managed with annual turnover of: 25.00 vs. VMCPX (13.00). CMJAX has a lower initial minimum investment than VMCPX: CMJAX (5000) vs VMCPX (100000000). CMJAX (25.35) and VMCPX (25.17) have marching annual gain over last year. CMJAX (58.08) and VMCPX (56.93) have equivalent 5 years return.
CMJAXVMCPXCMJAX / VMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years14 years-
Gain YTD11.72712.59393%
Front LoadN/AN/A-
Min. Initial Investment50001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets471M172B0%
Annual Yield % from dividends0.771.5151%
Returns for 1 year25.3525.17101%
Returns for 3 years7.259.8574%
Returns for 5 years58.0856.93102%
Returns for 10 yearsN/A128.75-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHR3.060.01
+0.33%
Archer Aviation
SBT4.64-0.02
-0.43%
Sterling Bancorp
EBAY62.75-0.47
-0.74%
eBay
CNXC63.38-0.79
-1.23%
Concentrix Corp
NRBO3.19-0.07
-2.15%
NeuroBo Pharmaceuticals